Ana Muñoz

5PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 12, 2024
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?

Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu

|Jun 28, 2023
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.

Laura Pons, Laura Hernández, Aintzane Urbizu

|Jun 27, 2023
Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.

Natalia Papaleo, Fina Climent, Gustavo Tapia

|Oct 27, 2020
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.

Anna Esteve-Codina, Francesc Alameda, Cristina Carrato

|Oct 01, 2020
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.

Cristina Carrato, Francesc Alameda, Anna Esteve-Codina

Pageof 1

Frequent Collaborators

2 joint publications

Anna Esteve-Codina

2 joint publications

Estela Pineda

2 joint publications

Maria Martinez-García

2 joint publications

Mar Mallo